Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deng-Fu Yao

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 6, 2007
Specific molecular markers in hepatocellular carcinomaDeng-Fu Yao, Zhi-Zhen Dong, Min Yao
Journal of Clinical and Translational Hepatology|September 11, 2015
Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular CarcinomaMin Yao, Li Wang, Yao Yao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 11, 2015
Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinomaLi Wang, Min Yao, Liu-Hong Pan, et al.
World Journal of Gastroenterology|April 10, 2023
Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesisMin Yao, Ping Zhou, Yan-Yan Qin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 26, 2004
[Clinical values of vascular endothelial growth factor expression and microvascular density analysis in liver cancer specimens]Deng-fu Yao, Yong Zhu, Xin-hua Wu, et al.
World Journal of Gastrointestinal Oncology|January 23, 2020
Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesisMiao Fang, Min Yao, Jie Yang, et al.
World Journal of Gastroenterology|September 1, 2018
Abnormal expression of <i>HMGB-3</i> is significantly associated with malignant transformation of hepatocytesWen-Jie Zheng, Min Yao, Miao Fang, et al.
World Journal of Gastrointestinal Oncology|July 12, 2024
Early monitoring values of oncogenic signalling molecules for hepatocellular carcinomaMin Yao, Rong-Fei Fang, Qun Xie, et al.
World Journal of Clinical Cases|May 25, 2022
Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinomaMin Yao, Jun-Ling Yang, De-Feng Wang, et al.
World Journal of Hepatology|January 2, 2025
Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinomaJun-Ling Yang, Jie Yang, Rong-Fei Fang, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 6, 2007
Specific molecular markers in hepatocellular carcinomaDeng-Fu Yao, Zhi-Zhen Dong, Min Yao
Journal of Clinical and Translational Hepatology|September 11, 2015
Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular CarcinomaMin Yao, Li Wang, Yao Yao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 11, 2015
Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinomaLi Wang, Min Yao, Liu-Hong Pan, et al.
World Journal of Gastroenterology|April 10, 2023
Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesisMin Yao, Ping Zhou, Yan-Yan Qin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 26, 2004
[Clinical values of vascular endothelial growth factor expression and microvascular density analysis in liver cancer specimens]Deng-fu Yao, Yong Zhu, Xin-hua Wu, et al.
World Journal of Gastrointestinal Oncology|January 23, 2020
Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesisMiao Fang, Min Yao, Jie Yang, et al.
World Journal of Gastroenterology|September 1, 2018
Abnormal expression of <i>HMGB-3</i> is significantly associated with malignant transformation of hepatocytesWen-Jie Zheng, Min Yao, Miao Fang, et al.
World Journal of Gastrointestinal Oncology|July 12, 2024
Early monitoring values of oncogenic signalling molecules for hepatocellular carcinomaMin Yao, Rong-Fei Fang, Qun Xie, et al.
World Journal of Clinical Cases|May 25, 2022
Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinomaMin Yao, Jun-Ling Yang, De-Feng Wang, et al.
World Journal of Hepatology|January 2, 2025
Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinomaJun-Ling Yang, Jie Yang, Rong-Fei Fang, et al.
Pageof 6